{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:30:14Z","timestamp":1778679014214,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,1,30]],"date-time":"2016-01-30T00:00:00Z","timestamp":1454112000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Programa de Apoyos para la Superaci\u00f3n Acad\u00e9mica de la UNAM (PASPA)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s11064-016-1840-1","type":"journal-article","created":{"date-parts":[[2016,1,30]],"date-time":"2016-01-30T02:06:13Z","timestamp":1454119573000},"page":"1365-1374","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Effect of the Anti-depressant Sertraline, the Novel Anti-seizure Drug Vinpocetine and Several Conventional Antiepileptic Drugs on the Epileptiform EEG Activity Induced by 4-Aminopyridine"],"prefix":"10.1007","volume":"41","author":[{"given":"Maria","family":"Sitges","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blanca Irene","family":"Aldana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald Charles","family":"Reed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,30]]},"reference":[{"key":"1840_CR1","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.neuropharm.2006.09.002","volume":"52","author":"M Sitges","year":"2007","unstructured":"Sitges M, Chiu LM, Guarneros A, Nekrassov V (2007) Effects of carbamazepine, phenytoin, lamotrigine, oxcarbazepine, topiramate and vinpocetine on Na+ channel-mediated release of [3H]glutamate in hippocampal nerve endings. Neuropharmacology 52:598\u2013605","journal-title":"Neuropharmacology"},{"key":"1840_CR2","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.neuropharm.2007.08.016","volume":"53","author":"M Sitges","year":"2007","unstructured":"Sitges M, Guarneros A, Nekrassov V (2007) Effects of carbamazepine, phenytoin, valproic acid, oxcarbazepine, lamotrigine, topiramate and vinpocetine on the presynaptic Ca2+ channel-mediated release of [3H]glutamate: comparison with the Na+ channel-mediated release. Neuropharmacology 53:854\u2013862","journal-title":"Neuropharmacology"},{"key":"1840_CR3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.eplepsyres.2011.06.006","volume":"96","author":"M Sitges","year":"2011","unstructured":"Sitges M, Sanchez-Tafolla BM, Chiu LM, Aldana BI, Guarneros A (2011) Vinpocetine inhibits glutamate release induced by the convulsive agent 4-aminopyridine more potently than several antiepileptic drugs. Epilepsy Res 96:257\u2013266","journal-title":"Epilepsy Res"},{"key":"1840_CR4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0920-1211(92)90016-M","volume":"11","author":"S Yamaguchi","year":"1992","unstructured":"Yamaguchi S, Rogawski MA (1992) Effects of anticonvulsant drugs on 4-aminopyridine-induced seizures in mice. Epilepsy Res 11:9\u201316","journal-title":"Epilepsy Res"},{"key":"1840_CR5","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1016\/j.clinph.2004.06.019","volume":"115","author":"M Sitges","year":"2004","unstructured":"Sitges M, Nekrassov V (2004) Vinpocetine prevents 4-aminopyridine-induced changes in the EEG, the auditory brainstem responses and hearing. Clin Neurophysiol 115:2711\u20132717","journal-title":"Clin Neurophysiol"},{"key":"1840_CR6","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s11064-005-8834-8","volume":"30","author":"G Mora","year":"2005","unstructured":"Mora G, Tapia R (2005) Effects of retigabine on the neurodegeneration and extracellular glutamate changes induced by 4-aminopyridine in rat hippocampus in vivo. Neurochem Res 30:1557\u20131565","journal-title":"Neurochem Res"},{"key":"1840_CR7","first-page":"245","volume":"53","author":"V Nekrassov","year":"2003","unstructured":"Nekrassov V, Sitges M (2003) Effects of pentylenetetrazole and 4-aminopyridine on the auditory brainstem response (ABR) and on the hearing sensitivity in the guinea pig in vivo. Brain Res 53:245\u2013254","journal-title":"Brain Res"},{"key":"1840_CR8","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1016\/j.clinph.2008.08.009","volume":"119","author":"V Nekrassov","year":"2008","unstructured":"Nekrassov V, Sitges M (2008) Comparison of acute, chronic and post-treatment effects of carbamazepine and vinpocetine on hearing loss and seizures induced by 4-aminopyridine. Clin Neurophysiol 119:2608\u20132614","journal-title":"Clin Neurophysiol"},{"key":"1840_CR9","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.yebeh.2012.09.005","volume":"25","author":"M Sitges","year":"2012","unstructured":"Sitges M, Aldana BI, Gomez CD, Nekrassov V (2012) The antidepressant sertraline prevents the behavioral and EEG changes induced in two animal models of seizures. Epilepsy Behav 25:511\u2013516","journal-title":"Epilepsy Behav"},{"key":"1840_CR10","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1111\/j.1471-4159.1989.tb09232.x","volume":"53","author":"GR Tibbs","year":"1989","unstructured":"Tibbs GR, Barrie AP, Van Mieghem FJE, McMahon HT, Nicholls DG (1989) Repetitive action potentials in isolated nerve terminals in the presence of 4-aminopyridine: effects on cytosolic free Ca2+ and glutamate release. J Neurochem 53:1693\u20131699","journal-title":"J Neurochem"},{"key":"1840_CR11","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1111\/j.1471-4159.1991.tb03437.x","volume":"156","author":"FM Heemskerk","year":"1991","unstructured":"Heemskerk FM, Schrama LH, Ghijsen WE, De Graan PN, Lopes da Silva FH, Gispen WH (1991) Presynaptic mechanism of action of 4-aminopyridine: changes in intracellular free Ca2+ concentration and its relationship to B-50 (GAP-43) phosphorylation. J Neurochem 156:1827\u20131835","journal-title":"J Neurochem"},{"key":"1840_CR12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1023\/B:NERE.0000013737.17288.ce","volume":"29","author":"E Galvan","year":"2004","unstructured":"Galvan E, Sitges M (2004) Characterization of the participation of sodium channels on the rise in Na+ induced by 4-aminopyridine (4-AP) in synaptosomes. Neurochem Res 29:347\u2013355","journal-title":"Neurochem Res"},{"key":"1840_CR13","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.neuint.2005.02.001","volume":"46","author":"M Sitges","year":"2005","unstructured":"Sitges M, Galvan E, Nekrassov V (2005) Vinpocetine blockade of sodium channels inhibits the rise in sodium and calcium induced by 4-aminopyridine in synaptosomes. Neurochem Int 46:533\u2013540","journal-title":"Neurochem Int"},{"key":"1840_CR14","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.yebeh.2003.10.003","volume":"4","author":"F Gilliam","year":"2003","unstructured":"Gilliam F, Hecimovic H, Sheline Y (2003) Psychiatric comorbidity, health and function in epilepsy. Epilepsy Behav Suppl 4:S26\u2013S30","journal-title":"Epilepsy Behav Suppl"},{"key":"1840_CR15","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1093\/brain\/awn194","volume":"131","author":"A Lothe","year":"2008","unstructured":"Lothe A, Didelot A, Hammers A, Costes M, Saoud M, Gilliam F, Ryvlin P (2008) Comorbidity between temporal lobe epilepsy and depression: a [18F]MPPF PET study. Brain 131:2765\u20132782","journal-title":"Brain"},{"key":"1840_CR16","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/WCO.0b013e3282f4e978","volume":"21","author":"AM Kanner","year":"2008","unstructured":"Kanner AM (2008) Depression in epilepsy: a complex relation with unexpected consequences. Curr Opin Neurol 21:190\u2013194","journal-title":"Curr Opin Neurol"},{"key":"1840_CR17","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.yebeh.2010.06.024","volume":"19","author":"AM Kanner","year":"2010","unstructured":"Kanner AM, Trimble M, Schmitz B (2010) Postictal affective episodes. Epilepsy Behav 19:156\u2013158","journal-title":"Epilepsy Behav"},{"key":"1840_CR18","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11940-011-0127-8","volume":"13","author":"KH Noe","year":"2011","unstructured":"Noe KH, Locke DE, Sirven JI (2011) Treatment of depression in patients with epilepsy. Curr Treat Options Neurol 13:371\u2013379","journal-title":"Curr Treat Options Neurol"},{"key":"1840_CR19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.expneurol.2011.05.023","volume":"233","author":"SC Danzer","year":"2011","unstructured":"Danzer SC (2011) Depression, stress, epilepsy and adult neurogenesis. Exp Neurol 233:22\u201332","journal-title":"Exp Neurol"},{"key":"1840_CR20","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1111\/j.1528-1167.2011.03133.x","volume":"52","author":"D Stevanovic","year":"2011","unstructured":"Stevanovic D, Jancic J, Lakic A (2011) The impact of depression and anxiety disorder symptoms on the health-related quality of life of children and adolescents with epilepsy. Epilepsia 52:e75\u2013e78","journal-title":"Epilepsia"},{"key":"1840_CR21","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.yebeh.2012.05.005","volume":"24","author":"H Hecimovic","year":"2012","unstructured":"Hecimovic H, Santos JM, Carter J, Attarian HP, Fessier AJ, Vahle V, Gilliam F (2012) Depression but not seizure factors or quality of life predicts suicidality in epilepsy. Epilepsy Behav 24:426\u2013429","journal-title":"Epilepsy Behav"},{"key":"1840_CR22","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.yebeh.2012.01.007","volume":"24","author":"AM Kanner","year":"2012","unstructured":"Kanner AM, Schachter SC, Barry JJ, Hersdorffer DC, Mula M, Trimble M, Herman B, Ettinger AE, Dunn D, Caplan R, Ryvlin P, Gilliam F (2012) Depression and epilepsy: epidemiologic and Neurobiologic perspectives that may explain their high comorbid occurrence. Epilepsy Behav 24:156\u2013168","journal-title":"Epilepsy Behav"},{"key":"1840_CR23","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrneurol.2012.69","volume":"8","author":"M Mula","year":"2012","unstructured":"Mula M (2012) Epilepsy: bidirectional link between epilepsy and psychiatric disorders. Nat Rev Neurol 8:252\u2013253","journal-title":"Nat Rev Neurol"},{"key":"1840_CR24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/YIC.0b013e3282f4b616","volume":"24","author":"DV Sheehan","year":"2009","unstructured":"Sheehan DV, Kamijima K (2009) An evidence-based review of the clinical use of sertraline in mood and anxiety disorders. Int Clin Psychopharmacol 24:43\u201360","journal-title":"Int Clin Psychopharmacol"},{"key":"1840_CR25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1471-4159.2012.07674.x","volume":"121","author":"BI Aldana","year":"2012","unstructured":"Aldana BI, Sitges M (2012) Sertraline inhibits pre-synaptic Na+ channel-mediated responses in hippocampus-isolated nerve endings. J Neurochem 121:197\u2013205","journal-title":"J Neurochem"},{"key":"1840_CR26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1358\/dot.2010.46.4.1445795","volume":"46","author":"D Vohora","year":"2010","unstructured":"Vohora D (2010) Recent advances in adjunctive therapy for epilepsy: focus on sodium channel blockers as third-generation antiepileptic drugs. Drugs Today 46:265\u2013277","journal-title":"Drugs Today"},{"key":"1840_CR27","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1097\/00001756-199806010-00034","volume":"9","author":"L Tretter","year":"1998","unstructured":"Tretter L, Adam-Vizi V (1998) The neuroprotective drug vinpocetine prevents veratridine-induced [Na+]i and [Ca2+]i rise in synaptosomes. NeuroReport 9:1849\u20131853","journal-title":"NeuroReport"},{"key":"1840_CR28","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1023\/A:1021164418478","volume":"24","author":"M Sitges","year":"1999","unstructured":"Sitges M, Nekrassov V (1999) Vinpocetine selectively inhibits neurotransmitter release triggered by sodium channel activation. Neurochem Res 24:1585\u20131591","journal-title":"Neurochem Res"},{"key":"1840_CR29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neuint.2005.12.019","volume":"49","author":"M Sitges","year":"2006","unstructured":"Sitges M, Chiu LM, Nekrassov V (2006) Single and combined effects of carbamazepine and vinpocetine on depolarization-induced changes in Na+, Ca2+ and glutamate release in hippocampal isolated nerve endings. Neurochem Int 49:55\u201361","journal-title":"Neurochem Int"},{"key":"1840_CR30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.eplepsyres.2004.05.005","volume":"60","author":"V Nekrassov","year":"2004","unstructured":"Nekrassov V, Sitges M (2004) Vinpocetine inhibits the epileptic cortical activity and auditory alterations induced by pentylenetetrazole in the guinea pig in vivo. Epilepsy Res 60:63\u201371","journal-title":"Epilepsy Res"},{"key":"1840_CR31","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0090-9556(25)07667-6","volume":"17","author":"LM Tremaine","year":"1989","unstructured":"Tremaine LM, Welch WM, Ronfeld RA (1989) Metabolism and disposition of the 5-hydroxytryptamine uptake blocker sertraline in the rat and dog. Drug Metab Dispos 17:542\u2013550","journal-title":"Drug Metab Dispos"},{"issue":"Suppl. 2","key":"1840_CR32","first-page":"92","volume":"55","author":"M Sitges","year":"2014","unstructured":"Sitges M, Garza-Morales S (2014) Effectiveness of a 12\u00a0h extended release formula of ethyl-apovincaminic acid in the control of seizures in patients with refractory epilepsy. Epilepsia 55(Suppl. 2):92\u201393","journal-title":"Epilepsia"},{"key":"1840_CR33","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","volume":"22","author":"S Reagan-Shaw","year":"2008","unstructured":"Reagan-Shaw S, Nihal M, Nihal A (2008) Dose translation from animal to human studies revisited. FASEB J 22:659\u2013661","journal-title":"FASEB J"},{"key":"1840_CR34","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/jnc.12784","volume":"130","author":"CD G\u00f3mez","year":"2014","unstructured":"G\u00f3mez CD, Buijs RM, Sitges M (2014) The anti-seizure drugs vinpocetine and carbamazepine, but not valproic acid, reduce inflammatory IL-1\u03b2 and TNF-\u03b1 expression in rat hippocampus. J Neurochem 130:770\u2013779","journal-title":"J Neurochem"},{"key":"1840_CR35","doi-asserted-by":"crossref","unstructured":"Schmidt D, Schachter S (2014) Drug treatment of epilepsy in adults. BMJ; 348-g2546","DOI":"10.1136\/bmj.g254"},{"key":"1840_CR36","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1017\/S1461145702002997","volume":"5","author":"J Bukanova","year":"2002","unstructured":"Bukanova J, Solntseva E, Skrebitsky V (2002) Selective suppression of the slow-inactivating potassium currents by nootropics in molluscan neurons. Int J Neuropsychopharmacol 5:229\u2013237","journal-title":"Int J Neuropsychopharmacol"},{"key":"1840_CR37","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/267720a0","volume":"267","author":"RL Macdonald","year":"1977","unstructured":"Macdonald RL, Barker JL (1977) Pentylenetetrazol and penicillin are selective antagonists of GABA-mediated post-synaptic inhibition in cultured mammalian neurones. Nature 267:720\u2013721","journal-title":"Nature"},{"key":"1840_CR38","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0301-0082(98)00075-6","volume":"58","author":"W L\u00f6scher","year":"1999","unstructured":"L\u00f6scher W (1999) Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action. Prog Neurobiol 58:31\u201359","journal-title":"Prog Neurobiol"},{"key":"1840_CR39","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00023210-200216100-00003","volume":"16","author":"W L\u00f6scher","year":"2002","unstructured":"L\u00f6scher W (2002) Basic pharmacology of valproate: a review after 35\u00a0years of clinical use for the treatment of epilepsy. CNS Drugs 16:669\u2013694","journal-title":"CNS Drugs"},{"key":"1840_CR40","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0024-3205(94)00845-0","volume":"54","author":"CL Cramer","year":"1994","unstructured":"Cramer CL, Stagnitto ML, Knowles MA, Palmer GC (1994) Kainic acid and 4-aminopyridine seizure models in mice: evaluation of efficacy of anti-epileptic agents and calcium antagonists. Life Sci 54:271\u2013275","journal-title":"Life Sci"},{"key":"1840_CR41","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1046\/j.1528-1157.2003.11603.x","volume":"44","author":"ED Mart\u00edn","year":"2003","unstructured":"Mart\u00edn ED, Pozo MA (2003) Valproate suppresses status epilepticus induced by 4-aminopyridine in CA1 hippocampus region. Epilepsia 44:1375\u20131379","journal-title":"Epilepsia"},{"key":"1840_CR42","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.neulet.2006.07.042","volume":"406","author":"V Nekrassov","year":"2006","unstructured":"Nekrassov V, Sitges M (2006) Additive effects of antiepileptic drugs and pentylenetetrazole on hearing. Neurosci Lett 406:276\u2013280","journal-title":"Neurosci Lett"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-016-1840-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-016-1840-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-016-1840-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T08:06:21Z","timestamp":1748765181000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-016-1840-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,30]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["1840"],"URL":"https:\/\/doi.org\/10.1007\/s11064-016-1840-1","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,30]]}}}